AVA Genomics Consultancy ApS
CVR 37493678 · Private limited company (ApS) · Active · Low risk
AVA Genomics Consultancy ApS is a Private limited company (ApS), founded on , based in Randers SV. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 0.1% over the next 12 months, which is 0.1 times the average for Danish companies. 10 annual reports have been published, of which 2 more than six months after the end of the financial year. The latest annual report (30 Jun 2026) shows equity of DKK 91k and a net result of DKK -4,294. CEO: Haja Najeemudin Kadarmideen.
Bankruptcy risk for AVA Genomics Consultancy ApS
0.1 × the average (1.41%) · higher risk than 38% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 37493678
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (10 years)
- Address
- c/o Haja Kadarmideen, CEO, Kærgade 64A
8940 Randers SV - Municipality
- Randers
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 40k
- Auditor
- midt revision ApS
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 2 of 10 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 99.7% |
| Current ratio | 34,547% |
| Moves (last 2 years) | 1 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 1 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2026 | 2025 | 2024 |
|---|---|---|---|
| Gross profit | DKK 15k | DKK 118k | DKK 433k |
| Net profit | DKK -4,294 | DKK -19k | DKK 251k |
| Equity | DKK 91k | DKK 95k | DKK 234k |
| Total assets | DKK 91k | DKK 97k | DKK 303k |
| Cash | DKK 85k | DKK 90k | – |
| Short-term debt | DKK 263 | DKK 2,240 | – |
| Tax owed | – | DKK 0 | – |
| Avg. employees | 1 | 1 | – |
Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · midt revision ApS.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jul 2025 – 30 Jun 2026 | 69 | ||
| 1 Jul 2024 – 30 Jun 2025 | 99 | ||
| 1 Jul 2023 – 30 Jun 2024 | 71 | ||
| 1 Jul 2022 – 30 Jun 2023 | 182 | ||
| 1 Jul 2021 – 30 Jun 2022 | 200 | Late | |
| 1 Jul 2020 – 30 Jun 2021 | 153 | ||
| 1 Jul 2019 – 30 Jun 2020 | 174 | ||
| 1 Jul 2018 – 30 Jun 2019 | 165 | ||
| 1 Jul 2017 – 30 Jun 2018 | 174 | ||
| 1 Mar 2016 – 30 Jun 2017 | 207 | Late |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Haja Najeemudin Kadarmideen | Current | |
| Owner (100%) | Haja Najeemudin Kadarmideen | Current | |
| Founder | Haja Najeemudin Kadarmideen | Current |
The CEOs' other companies
Haja Najeemudin Kadarmideen – 1 other companies
- Synomics ApS Opløst
Address history (2 moves)
| c/o Haja Kadarmideen, CEO, Kærgade 64A, 8940 Randers SV | |
| c/o Haja Kadarmideen, CEO, Ålegårdsvej 63, 2740 Skovlunde | |
| Engblommevej 42, 2400 København NV |
Former names
| AVA Genomics Consultancy ApS | – now |
| AVA Genomics and Breeding Consultancy IVS | – |
Other companies at the same address
- BLIKTUDEN EJENDOMME ApS Opløst
Similar companies in Randers
- Serprozyme ApS Randers SV
- Cannabis Pharm ApS Randers SØ
- Selskabet af 12. september 2022 A/S Langå
Questions and answers about AVA Genomics Consultancy ApS
Has AVA Genomics Consultancy ApS gone bankrupt?
No, AVA Genomics Consultancy ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of AVA Genomics Consultancy ApS?
Our model estimates a bankruptcy risk of 0.1% over the next 12 months (low risk), which is 0.1 times the average for Danish companies.
Who is the CEO of AVA Genomics Consultancy ApS?
Haja Najeemudin Kadarmideen is the CEO of AVA Genomics Consultancy ApS.
Who is the auditor of AVA Genomics Consultancy ApS?
AVA Genomics Consultancy ApS most recently used midt revision ApS.
When was AVA Genomics Consultancy ApS founded?
AVA Genomics Consultancy ApS was founded on 26 February 2016.
What is the equity of AVA Genomics Consultancy ApS?
Equity was DKK 91k according to the annual report for the period ending 30 June 2026.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.